Ushbu ish iqtibos qilgan ishlar

21 ta ish

Ish: Clinical efficiency of restorative treatment after percutaneous coronary intervention in patients with coronary artery disease

1. Influence of abnormal lipid components in statin-naive young adults: Is there any gap?

   Jamol Uzokov

   BoshqaLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology201910 iqtibos

   ABIABI:AkademIndex/2019.other.000001

2. GW28-e0699 Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome

   Alyavi Anis Lutfullayevich, Alyavi Baxrom Anisxonovich, Uzokov Jamol Kamilovich +2

   MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsJournal of the American College of Cardiology20177 iqtibos

   ABIABI:AkademIndex/2017.article.000213

3. P2533Influence of l-arginine aspartate on vascular markers in hypertensive patients with metabolic syndrome

   М. А. Бабаев, A. L. Alyavi, Bakhromkhon Alyavi +1

   MaqolaHyperglycemia and glycemic control in critically ill and hospitalized patientsEuropean Heart Journal20186 iqtibos

   ABIABI:AkademIndex/2018.article.000250

4. Relationship between hemodynamic parametres and NPPA, NPPB, npr3 genes polymorphism in patients with ischemic heart disease

   Alyavi Anis Lyutfullayevich, Tulyaganova Dildora Karimovna, Sabirjanova Zulfiya Talgatovna +4

   Maqola20176 iqtibos

   ABIABI:AkademIndex/2026.other.620201

5. PS 11-56 EFFICACY OF COMBINATION THERAPY USING NEBIVALOL AND TRIMETAZIDINE IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME AND STABLE ANGINA

   Muzaffar Usarov, Xasan Mamatkulov, Jamol Uzokov +3

   MaqolaHormonal Regulation and HypertensionJournal of Hypertension20165 iqtibos

   ABIABI:AkademIndex/2016.article.000246

6. Comparative Analysis Of The Inflammatory Biomarkers In Patients With Stable Coronary Artery Disease And Metabolic Syndrome

   Sherzod Iskhakov, Jamol Uzokov, S. E. Kamilova

   MaqolaCardiovascular Disease and AdiposityAtherosclerosis20195 iqtibos

   ABIABI:AkademIndex/2019.article.000369

7. P120Relationship between left ventricular global function index and cardiac systolic functions in patients with chronic ischemic disease of the heart and diabetes mellitus

   M.G. Mukhamedova, B. A. Alyavi, Jamol Uzokov +2

   MaqolaCardiovascular Function and Risk FactorsEuropean Heart Journal - Cardiovascular Imaging20195 iqtibos

   ABIABI:AkademIndex/2019.article.000381

8. Journal of The American College of Cardiology

   Maqola20155 iqtibos

   ABIABI:AkademIndex/2026.other.532305

9. GW28-e0698 Telmisartan with amlodipine versus lisinopril with amlodipine on home blood pressure variability in patients with metabolic syndrome

   Alyavi Anis Lutfullayevich, Alyavi Baxrom Anisxonovich, Uzokov Jamol Kamilovich +2

   MaqolaOAOchiq kirishBlood Pressure and Hypertension StudiesJournal of the American College of Cardiology20174 iqtibos

   ABIABI:AkademIndex/2017.article.000262

10. Influence of Diet with Low Glycemic Index on Lipid Spectrum in Patients with Ischemic Disease of the Heart

    Anis Alyavi, Baxrom Alyavi, Jamol Uzokov +1

    MaqolaLiver Disease Diagnosis and TreatmentAtherosclerosis Supplements20184 iqtibos

    ABIABI:AkademIndex/2018.article.000278

11. A Survey on Cardiovascular Nursing Occupational Standard: Meeting the Needs of Employers

    Ivica Matić, Erika Sivarajan Froelicher, Jamol Uzokov +1

    MaqolaOccupational Health and Safety ResearchPolicy Politics & Nursing Practice20204 iqtibos

    ABIABI:AkademIndex/2020.article.000459

12. Role of pro-inflammatory cytokines in metabolic syndrome

    Jamol Uzokov

    Preprint20184 iqtibos

    ABIABI:AkademIndex/2026.other.628417

13. EFFICACY OF ROSUVASTATIN ON LIPID PARAMETERS AND VASCULAR AND INFLAMMATORY MARKERS IN PATIENTS WITH METABOLIC SYNDROME AND CORONARY ARTERY DISEASE

    Mukhamedova Muyassar Gafurjanovna, Narzullaeva Dildora Saidjanovna, Jamol Uzokov

    Maqola20204 iqtibos

    ABIABI:AkademIndex/2026.other.687758

14. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease

    Jamol Uzokov, Bakhromkhon Alyavi, Djamshid Payziev

    MaqolaLiver Disease Diagnosis and TreatmentAtherosclerosis20203 iqtibos

    ABIABI:AkademIndex/2020.article.000731

15. Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome

    Jamol Uzokov, Tashkent, Uzbekistan, B. A. Alyavi +5

    Sharh maqola20203 iqtibos

    ABIABI:AkademIndex/2026.other.620202

16. Combination lipid lowering therapy with rosuvastatin and ezetimibe in dyslipidemic patients with stable coronary artery disease and metabolic syndrome

    Jamol Uzokov, B. A. Alyavi

    MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20182 iqtibos

    ABIABI:AkademIndex/2018.article.000349

17. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.687759

18. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.687760

19. Influence of combination therapy of rosuvastatin and telmisartan on vascular and metabolic profile in hypercholesterolemic patients with metabolic syndrome

    Jamol Uzokov, Anis Alyavi, Baxrom Alyavi

    MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20171 iqtibos

    ABIABI:AkademIndex/2017.article.000354

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.687756

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.687757